Identification of Crucial Gene Modules Related to the Efficiency of Anti-PD-1/PD-L1 Therapy and Comprehensive Analyses of a Novel Signature Based on These Modules

Biomarker development for clinical checkpoint inhibition is still in its early stages. It is critical to determine the cause of the lack of a long-term response in patients after immune checkpoint blockade (ICB) treatment and to develop composite biomarkers or signatures to improve personalized appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Dong, Dong, Chen, Liang, Wang, Heng, Bi, Bo, Liu, Tianyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354784/
https://www.ncbi.nlm.nih.gov/pubmed/35937997
http://dx.doi.org/10.3389/fgene.2022.893380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354784/
https://www.ncbi.nlm.nih.gov/pubmed/35937997
http://dx.doi.org/10.3389/fgene.2022.893380

Ejemplares similares